Kashiv BioSciences Acquired by Amneal Pharmaceuticals | Healthcare M&A Deal

Amneal Pharmaceuticals has acquired Kashiv BioSciences, a pharmacy business in New Jersey, for an undisclosed amount. Kashiv BioSciences develops and commercializes biosimilars, supporting Amneal Pharmaceuticals’ plan to expand a fully integrated global biosimilars platform. Amneal Pharmaceuticals acquisitions in healthcare M&A focus on strengthening manufacturing, regulatory, and market access capabilities tied to biosimilar products. The merger acquisition is a strategic acquisition by a strategic buyer, positioning Amneal Pharmaceuticals for broader global scale in biosimilars. Deal status is announced, with terms and closing timing not disclosed.